The Price of Innovation: ‘Paying for a Cure’ Remains Costly Proposition
PharmExec
AUGUST 10, 2022
What is being done to smooth the path for pricing and reimbursement? Curative-type therapies offer great hope in further transforming treatments for cancer and other diseases, but addressing the economics of these products—and ultimately the cost-benefit equation—is daunting.
Let's personalize your content